Related Experiment Video
Updated: Jul 14, 2026

13:56
Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
Published on: November 28, 2012
9.8K
Influence of Cataract Causing Mutations on αA-Crystallin: A Computational Approach.
Kajal Abrol1, Jayarani Basumatari1, Jupita Handique1
1Department of Bioinformatics, Pondicherry University, Pondicherry, 605014, India.
The Protein Journal
|November 1, 2024
Summary
Mutations in alphaA-crystallin (αA-crystallin) disrupt eye lens structure, causing cataracts. Computer simulations show these mutations increase protein flexibility and dynamics, leading to instability and potential unfolding.
Area of Science:
- Biophysics
- Structural Biology
- Ocular Science
Background:
- AlphaA-crystallin (αA-crystallin) is crucial for maintaining eye lens transparency and refractive index.
- Mutations in αA-crystallin are linked to cataract formation due to protein aggregation.
- Understanding mutation-induced structural changes is key to addressing cataract etiology.
Purpose of the Study:
- To investigate the structural and functional impact of cataract-causing mutations in αA-crystallin.
- To elucidate the role of N-Terminal and α-Crystallin Domains in mutation-induced effects.
- To utilize in-silico methods, specifically molecular dynamics simulations, for comprehensive analysis.
Main Methods:
- Performed 100 ns molecular dynamics simulations for 19 αA-crystallin mutants and the native structure.
- Analyzed simulation data to assess protein dynamics, flexibility, and structural compactness.
- Investigated changes in secondary structure elements, domain dynamics, and interaction profiles.
Main Results:
- Simulations revealed increased structural flexibility and dynamics in mutants, losing native compactness.
- N-Terminal Domain (NTD) motions were identified as dominant, correlated with overall protein dynamics.
- Enhanced dynamics were linked to increased non-covalent and hydrophobic interactions, promoting instability and unfolding.
Conclusions:
- Mutation-mediated structural distortions in αA-crystallin significantly impact protein stability.
- Enhanced protein dynamics and flexibility are key features of cataract-associated mutants.
- Findings suggest a need for developing inhibitors to prevent mutation-induced cataract formation.
Related Concept Videos
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Factors Affecting α-Alkylation of Ketones: Choice of Base
α-Alkylation of ketones is achieved in the presence of alkyl halides and a base. The reaction proceeds via the formation of an enolate ion followed by nucleophilic substitution. The choice of base employed is essential as it is the key factor in determining the reaction outcome.
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence, side reactions...
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence, side reactions...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

